These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24947718)

  • 1. Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational data.
    Granger CB; Rao MP
    JACC Cardiovasc Interv; 2014 Jun; 7(6):602-3. PubMed ID: 24947718
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
    JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.
    Ozasa N; Kimura T; Morimoto T; Hou H; Tamura T; Shizuta S; Nakagawa Y; Furukawa Y; Hayashi Y; Nakao K; Matsuzaki M; Nobuyoshi M; Mitsudo K;
    Am J Cardiol; 2010 Nov; 106(9):1225-33. PubMed ID: 21029817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era.
    Nakatani D; Sakata Y; Suna S; Usami M; Matsumoto S; Shimizu M; Hara M; Uematsu M; Fukunami M; Hamasaki T; Sato H; Hori M; Komuro I;
    Am J Cardiol; 2013 Feb; 111(4):457-64. PubMed ID: 23228922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction.
    Bao B; Ozasa N; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tada T; Tazaki J; Kato Y; Hayano M; Natsuaki M; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T
    Cardiovasc Interv Ther; 2013 Apr; 28(2):139-47. PubMed ID: 23054967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.
    Mohammad MA; Andell P; Koul S; Desta L; Jernberg T; Omerovic E; Spaak J; Fröbert O; Jensen J; Engstrøm T; Hofman-Bang C; Persson H; Erlinge D
    EuroIntervention; 2017 Jun; 13(2):e210-e218. PubMed ID: 28242589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of immediate beta-blocker therapy on mortality in patients with ST-segment elevation myocardial infarction.
    Hirschl MM; Wollmann CG; Erhart F; Brunner W; Pfeffel F; Gattermeier M; Steger F; Mayr H
    Crit Care Med; 2013 Jun; 41(6):1396-404. PubMed ID: 23528803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-Analysis of Relation Between Oral β-Blocker Therapy and Outcomes in Patients With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention.
    Huang BT; Huang FY; Zuo ZL; Liao YB; Heng Y; Wang PJ; Gui YY; Xia TL; Xin ZM; Liu W; Zhang C; Chen SJ; Pu XB; Chen M; Huang DJ
    Am J Cardiol; 2015 Jun; 115(11):1529-38. PubMed ID: 25862157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
    Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
    Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis.
    Misumida N; Harjai K; Kernis S; Kanei Y
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):280-5. PubMed ID: 26424094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of beta-blocker therapy at discharge on long-term mortality after primary angioplasty for ST-segment elevation myocardial infarction.
    De Luca G; de Boer MJ; Ottervanger JP; van 't Hof AW; Hoorntje JC; Gosselink AT; Dambrink JH; Suryapranata H
    Am J Cardiol; 2005 Sep; 96(6):806-9. PubMed ID: 16169366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of local delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (the delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [DISSOLUTION] randomized trial).
    Greco C; Pelliccia F; Tanzilli G; Tinti MD; Salenzi P; Cicerchia C; Schiariti M; Franzoni F; Speziale G; Gallo P; Gaudio C
    Am J Cardiol; 2013 Sep; 112(5):630-5. PubMed ID: 23711809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the clinical characteristics and hospital treatment of myocardial infarction with and without ST-segment elevation in Hungary. National Registry of Myocardial Infarction].
    Breuer T; Jánosi A; Szüts K; Andréka P; Ofner P
    Orv Hetil; 2014 May; 155(21):828-32. PubMed ID: 24836318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic significance of the culprit vessel in patients with ST-elevation myocardial infarction treated with primary coronary intervention].
    Jánosi A; Ofner P; Simkovits D; Ferenci T
    Orv Hetil; 2016 Aug; 157(32):1282-8. PubMed ID: 27499287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of β-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis.
    Konishi H; Miyauchi K; Kasai T; Tsuboi S; Ogita M; Naito R; Nishizaki Y; Okai I; Tamura H; Okazaki S; Isoda K; Daida H
    Heart Vessels; 2016 Apr; 31(4):441-8. PubMed ID: 25573259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of door-to-activation time on door-to-balloon time in primary percutaneous coronary intervention for ST-segment elevation myocardial infarctions: a report from the Activate-SF registry.
    McCabe JM; Armstrong EJ; Hoffmayer KS; Bhave PD; MacGregor JS; Hsue P; Stein JC; Kinlay S; Ganz P
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):672-9. PubMed ID: 22949494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.